Form D · Biotechnology
PACEpartners Inc.
Pine Bluff, AR · CIK 0001575086
Offering snapshot reported Apr 25, 2013 · SEC filing
- Reported sold
- $9.04M Offering amount: $9.04M
- Investors reported
- 20 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Apr 19, 2013 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 25, 2013 | Initial | $9,035,840 | No comparison | 20 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- Yes
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-195569
The shares issued in the Vivione merger and an additional 234,514 Class A and 938,055 Class B common shares issued to certain Vivione members in satisfaction of bridge loans and salary deferrals,the Issuer's shares were valued at CAD $.25 each.
Source: Form D, filed Apr 25, 2013. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Ian E. Gallie | Director |
| Chester J. Jachimiec | Executive |
| Kevin Kuykendall | Director, Executive |
| Ted J. Moskal | Director, Executive |
| C. Lai Narang | Director |
| Philip A. Tuttle | Director, Promoter |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
34 161 Hoadley Road
Pine Bluff, AR, 71602-9500
Pine Bluff, AR, 71602-9500